Virtual Medicinal Product (VMP) - Mesalazine 300mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Mesalazine 300mg/5ml oral suspension | Start Date 22-06-2016 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- A07EC02
- BNF Codes
-
- BNF code 01050100
| Code | Start Date | End Date |
|---|---|---|
| 32878411000001101 | 22-06-2016 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Mesalazine | Based on Ingredient Substance | 60 mg | 1 ml |
Name
Mesalazine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
60
Strength and UOM (Dmr)
1
Parent Products
-
VTMMesalazine
-
VMP(Current) Mesalazine 300mg/5ml oral suspension
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml |